BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 33987826)

  • 1. Neurological development of children who are HIV-exposed and uninfected.
    Toledo G; Côté HCF; Adler C; Thorne C; Goetghebuer T
    Dev Med Child Neurol; 2021 Oct; 63(10):1161-1170. PubMed ID: 33987826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated Blood Mitochondrial DNA in Early Life Among Uninfected Children Exposed to Human Immunodeficiency Virus and Combination Antiretroviral Therapy in utero.
    Ajaykumar A; Zhu M; Kakkar F; Brophy J; Bitnun A; Alimenti A; Soudeyns H; Saberi S; Albert AYK; Money DM; Côté HCF;
    J Infect Dis; 2021 Feb; 223(4):621-631. PubMed ID: 32638023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of in-utero antiretroviral exposure: neurologic outcomes in children who are HIV-exposed but uninfected.
    Crowell CS; Williams PL; Yildirim C; Van Dyke RB; Smith R; Chadwick EG; Seage GR; Diperna A; Hazra R;
    AIDS; 2020 Jul; 34(9):1377-1387. PubMed ID: 32310900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurodevelopment and in utero antiretroviral exposure of HIV-exposed uninfected infants.
    Williams PL; Marino M; Malee K; Brogly S; Hughes MD; Mofenson LM;
    Pediatrics; 2010 Feb; 125(2):e250-60. PubMed ID: 20083530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Growth differences by school-age and adolescence according to in utero and peripartum antiretroviral therapy exposure among Ugandan children.
    Awadu JE; Zalwango SK; Sikorskii A; Giordani B; Bovin MJ; Musoke PM; Ezeamama AE
    Medicine (Baltimore); 2023 Jan; 102(4):e32677. PubMed ID: 36705393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodevelopment of children who are HIV-exposed and uninfected in Kenya.
    Bulterys MA; Njuguna I; King'e M; Chebet D; Moraa H; Gomez L; Onyango A; Malavi K; Nzia G; Chege M; Neary J; Wagner AD; Lawley KA; Wamalwa D; Benki-Nugent S; John-Stewart G
    J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26149. PubMed ID: 37909174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In utero and postnatal exposure to antiretrovirals among HIV-exposed but uninfected children in the United States.
    Griner R; Williams PL; Read JS; Seage GR; Crain M; Yogev R; Hazra R; Rich K;
    AIDS Patient Care STDS; 2011 Jul; 25(7):385-94. PubMed ID: 21992592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurodevelopmental and behavioural outcomes of HIV-exposed uninfected and HIV-unexposed children at 2-3 years of age in Cape Town, South Africa.
    Springer PE; Slogrove AL; Kidd M; Kalk E; Bettinger JA; Esser MM; Cotton MF; Zunza M; Molteno CD; Kruger M
    AIDS Care; 2020 Apr; 32(4):411-419. PubMed ID: 31280587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurodevelopmental effects of ante-partum and post-partum antiretroviral exposure in HIV-exposed and uninfected children versus HIV-unexposed and uninfected children in Uganda and Malawi: a prospective cohort study.
    Boivin MJ; Maliwichi-Senganimalunje L; Ogwang LW; Kawalazira R; Sikorskii A; Familiar-Lopez I; Kuteesa A; Nyakato M; Mutebe A; Namukooli JL; Mallewa M; Ruiseñor-Escudero H; Aizire J; Taha TE; Fowler MG
    Lancet HIV; 2019 Aug; 6(8):e518-e530. PubMed ID: 31122797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early child development in children who are HIV-exposed uninfected compared to children who are HIV-unexposed: observational sub-study of a cluster-randomized trial in rural Zimbabwe.
    Ntozini R; Chandna J; Evans C; Chasekwa B; Majo FD; Kandawasvika G; Tavengwa NV; Mutasa B; Mutasa K; Moulton LH; Humphrey JH; Gladstone MJ; Prendergast AJ;
    J Int AIDS Soc; 2020 May; 23(5):e25456. PubMed ID: 32386127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams.
    Culnane M; Fowler M; Lee SS; McSherry G; Brady M; O'Donnell K; Mofenson L; Gortmaker SL; Shapiro DE; Scott G; Jimenez E; Moore EC; Diaz C; Flynn PM; Cunningham B; Oleske J
    JAMA; 1999 Jan; 281(2):151-7. PubMed ID: 9917118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Utero Antiretroviral Exposure and Risk of Neurodevelopmental Problems in HIV-Exposed Uninfected 5-Year-Old Children.
    Yao TJ; Malee K; Zhang J; Smith R; Redmond S; Rice ML; Frederick T; Torre P; Mellins CA; Hoffman HJ; Williams PL
    AIDS Patient Care STDS; 2023 Mar; 37(3):119-130. PubMed ID: 36827595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurodevelopment among children exposed to HIV and uninfected in sub-Saharan Africa.
    Bulterys MA; Njuguna I; Mahy M; Gulaid LA; Powis KM; Wedderburn CJ; John-Stewart G
    J Int AIDS Soc; 2023 Oct; 26 Suppl 4(Suppl 4):e26159. PubMed ID: 37909232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants.
    Williams PL; Crain MJ; Yildirim C; Hazra R; Van Dyke RB; Rich K; Read JS; Stuard E; Rathore M; Mendez HA; Watts DH;
    JAMA Pediatr; 2015 Jan; 169(1):48-55. PubMed ID: 25383770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of maternal antiretroviral use with microcephaly in children who are HIV-exposed but uninfected (SMARTT): a prospective cohort study.
    Williams PL; Yildirim C; Chadwick EG; Van Dyke RB; Smith R; Correia KF; DiPerna A; Seage GR; Hazra R; Crowell CS;
    Lancet HIV; 2020 Jan; 7(1):e49-e58. PubMed ID: 31740351
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Language outcomes of preschool children who are HIV-exposed uninfected: An analysis of a South African cohort.
    Green F; du Plooy C; Rehman AM; Nhapi RT; Lake MT; Barnett W; Hoffman N; Zar HJ; Donald KA; Stein DJ; Wedderburn CJ
    PLoS One; 2024; 19(4):e0297471. PubMed ID: 38598467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurodevelopmental outcomes and in-utero antiretroviral exposure in HIV-exposed uninfected children.
    Piske M; Budd MA; Qiu AQ; Maan EJ; Sauvé LJ; Forbes JC; Alimenti A; Janssen P; Côté HCF;
    AIDS; 2018 Nov; 32(17):2583-2592. PubMed ID: 30134292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiretroviral therapy during pregnancy and early neonatal life: consequences for HIV-exposed, uninfected children.
    El Beitune P; Duarte G; Quintana SM; Figueiró-Filho EA; Marcolin AC; Abduch R
    Braz J Infect Dis; 2004 Apr; 8(2):140-50. PubMed ID: 15361992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurodevelopment of HIV-exposed uninfected children in South Africa: outcomes from an observational birth cohort study.
    Wedderburn CJ; Yeung S; Rehman AM; Stadler JAM; Nhapi RT; Barnett W; Myer L; Gibb DM; Zar HJ; Stein DJ; Donald KA
    Lancet Child Adolesc Health; 2019 Nov; 3(11):803-813. PubMed ID: 31515160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antenatal and neonatal antiretroviral therapy in HIV-infected women and their infants: a review of safety issues.
    Thorne C; Newell ML
    Med Wieku Rozwoj; 2003; 7(4 Pt 1):425-36. PubMed ID: 15010553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.